In a randomized, double-blind study of 30 CHF patients, all of whom had been taking furosemide (80 mg/day) for at least three months, intravenous (IV) thiamin therapy (200 mg/day) for seven days resulted in an improved LVEF compared to IV placebo (80)
Related products + compare TAURINE 850.00Select options + compare curcumin complex 650.00 1,250.00Price range: 650.00 through 1,250.00Select options + compare SIDDA CORDIFOLIA 850.00Select options + compare BURDOCK 570.00 950.00Price range: 570.00 through 950.00Select options + compare GARCINIA 850.00Select options
Pain Management DSIP demonstrates analgesic properties by modulating central opioid receptors ( 6, 7 )
GLP-1 therapy boosts visceral fat metabolism, driving weight loss
Common IGF-1 LR3 SubQ dose context (research planning, not clinical guidance) Phase Assessment Daily dose 20 mcg/day Frequency Once daily Notes Used to gauge tolerance and hypoglycemic response
Sci Transl Med 2020;12:eaay8071.ArticlePubMedPMC 105